In this issue of Neuron, Lin et al. (2013) describe InSynC, an optogenetic approach that utilizes chromophoreassisted light inactivation (CALI) to inactivate presynaptic neurotransmitter release proteins VAMP2 and synaptophysin. InSynC selectively reduces synaptic transmission in illuminated regions in vitro and in vivo.
Optogenetics has revolutionized neuroscience through the use of heterologously expressed light-sensitive opsins that are G protein-coupled receptors, ion channels, or pumps to stimulate or inhibit activity in genetically selected neurons and brain regions, opening exciting avenues to probe the role of those cells in circuit function and behavior (Szobota and Isacoff, 2010; Miesenbö ck, 2011; Yizhar et al., 2011) . In addition to naturally light-sensitive opsins used in ''classical'' optogenetics, chemical synthesis combined with protein engineering has produced a complementary ''chemical'' optogenetics, or photopharmacology, in which native mammalian channels, as well as ionotropic and metabotropic receptors, can be blocked, agonized, or antagonized by light, enabling presynaptic or postsynaptic neuronal responses to neurotransmitter release to be selectively controlled (Kramer et al., 2013; Levitz et al., 2013) . While the optical activation of presynaptic rhodopsin can partially inhibit transmitter release during illumination (Li et al., 2005) and a light-activated metabotropic glutamate receptor can do so and persist for many minutes in the dark (Levitz et al., 2013) and both can be rapidly turned off, a method for ablation of neurotransmitter release that lasts for many hours has been missing from the optogenetic quiver.
An exciting first success in the optical manipulation of the transmitter release apparatus was developed a decade ago using chromophore-assisted light inactivation (CALI) (Marek and Davis, 2002) . CALI can be used to selectively inactivate proteins during excitation of a nearby chromophore that generates reactive oxygen species (Jay, 1988) . Synthetic chromophores can be used (Jay, 1988; Marek and Davis, 2002) , turning the tendency of the fluorophore to enter into a dark triplet state into something productive by using it as photosensitizer for exciting oxygen. To use a synthetic fluorophore in such an application, it needs to be targeted to the protein of interest-a challenge in the complex environment of the cell, especially in the cytoplasm, where the transmitter-release apparatus is located. An elegant solution for protein targeting, developed by Tsien and coworkers, is to use biarsenal fluorophores that bind tightly and specifically to an introduced tetracysteine sequence (Griffin et al., 1998) . This approach was used successfully to target the calcium sensor of transmitter release, synaptotagmin, and thereby to block synaptic transmission in Drosophila motor nerve terminals (Marek and Davis, 2002) . However, biarsenal fluorophore targeting works well in some proteins and has been a challenge in others, despite considerable improvements to the methodology (Hoffmann et al., 2010) . This has led to a search for other methods by which a singlet oxygen generator can be targeted to a specific protein.
The solution seemed to be at hand when CALI was demonstrated with genetically encoded chromophores such as eGFP and KillerRed (Bulina et al., 2006) , suggesting that standard and highly generalizable fluorescent protein fusions to the protein target could be the answer-an even more powerful strategy because it would be entirely genetically encoded. But these fluorescent protein-based techniques remain less efficient.
The solution has now been achieved, as reported in this issue of Neuron by Lin et al. (2013) , using another class of protein chromophore. The protein to which they turn is the engineered flavoprotein miniSOG (singlet oxygen generator). The flavin mononucleotide that binds to miniSOG has a higher quantum efficiency for singlet oxygen photogeneration than GFP or KillerRed. By analogy with the retinal chromophore of opsins in classical optogenetics, flavin mononucleotide is present naturally at sufficient levels in cells so that the system depends simply on where miniSOG is expressed; that is to say, it is entirely genetically encoded. The approach was used recently by the group to kill genetically targeted neurons in Caenorhabditis elegans (Qi et al., 2012) . The goal now was more refined: to selectively disable the SNARE proteins of the transmitter release apparatus. Lin et al. (2013) fused miniSOG to the SNARE protein VAMP2 (a.k.a. synaptobrevin2) and the synaptic vesicle protein synaptophysin with the aim of inactivating the secretion complex with light. They demonstrate reduction of synaptic transmission electrophysiologically in hippocampal neurons in response to 480 nm light, which excites the flavin mononucleotide. Moreover, they use the styryl dye FM 4-64 to show that the effect is due to decreased stimulus-evoked vesicle cycling, consistent with a block of transmitter release. Importantly, the block occurs only in illuminated regions, indicating that, beyond the ability to genetically specify the cell type in which transmission inactivation occurs via the cell type-specific expression of the construct, light patterns can be used to select a subset of the responsive terminals for inactivation.
Taking the system through its paces, Lin et al. (2013) demonstrate that it works in organotypic slice from hippocampus, where the native circuitry is largely preserved, and that it works too in vivo in C. elegans. The experiments in C. elegans reveal another valuable property of the system: recovery. A day after animals are paralyzed by light they recover some movement, suggesting that protein turnover reverses the synaptic inactivation. Finally, one does not need to replace the native gene with the miniSOG-fused version for the system to work. It works under conditions of overexpression, consistent with prior evidence that overexpressed VAMP2 and synaptophysin function in wild-type neurons where the native copies are present, while preserving close-to-normal release in the case of VAMP2, although the overexpression of synaptophysin can alter release (Alder et al., 1995; Degtyar et al., 2013) .
Since VAMPs and synaptophysin are broadly used for transmitter release, these very tools can immediately be used to inhibit the release of either excitatory or inhibitory classical transmitters with light. One hopes that very soon variants will be available that target the dense core vesicle apparatus and the SNARE proteins of astrocytes to selectively inactivate peptidergic transmission and some forms of gliotransmission. At any rate, the ability to target expression genetically and aim light should make it possible to inhibit specific axonal projections and provide a powerful new option for circuit dissection (Figure 1 ).
All good inventions need catchy names and, through some linguistic calisthenics, Lin et al. (2013) arrive at a euphonic (but oy, the capitals!) ''InSynC'' via the mouthful ''Inhibition of Synapses with CALI,'' whose ''C,'' recall, is an acronym of its own. The results well justify both the acronym and the decade-long wait.
